Table 2 Clinical indexes in relation to DTL expression status in the bladder samples

Age

 > 65

59

16

23

1.0402

0.3078

 ≤ 65

11

9

Gender

 Female

59

4

5

0.0074

1

 Male

23

27

Survival status

 0

59

10

18

2.1679

0.1409

 1

17

14

Survival time

 > 3(year)

59

20

15

4.4895

0.0341

 ≤ 3(year)

7

17

Grade

 Low-grade BLCA

55

20

25

0.8707

0.3612

 Middle-grade BLCA

2

1

 High-grade BLCA

4

3

Stage

 0is

55

3

1

9.6095

0.0436

 1

9

3

 2

3

7

 3

10

16

 4

0

3

Cancer

 cancer

70

27

32

4. 8251

0.028

 adjacent tissues

9

2

CD3

 ≤ 10%

56

2

21

18.599

0

 > 10%

25

11